Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidazopyrazines as Raf inhibitor compounds

Imidazopyrazines as Raf inhibitor compounds

US Patent 7566716 · Granted Jul 28, 2009

Estimated economic value: $3,368,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HER2 mutation inhibitors2025
Compounds, compositions and methods2025
Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators2025
Compounds for the treatment of BRAF-associated diseases and disorders2025
KV7 channel activators compositions and methods of use2025
5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases2025
Imaging methods using deuterated compounds2025
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I r2024
Aryl ethers and uses thereof2024
KRas G12D inhibitors2024
Inhibiting agents for bruton's tyrosine kinase2024
Substituted pyrimidines as LRKK2 inhibitors2023